Treace Medical Concepts, Inc. Share Price & Technical Analysis

TMCI · $2.78 (-2.11%)

Healthcare / Medical Devices

AI Score 51 · Weak

$2.78

-2.11%

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Mi

Price chart

Seasonality

May has 2 positive and 3 negative years (last 5 years shown)

56% return in May, -20% avg return in past 3 year May month.

31% return in 2026, -39% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-8%-17%-28%29%56%31%
2535%-9%-6%-15%-24%4%-8%38%-8%-4%-53%-14%-66%
248%-2%-3%-20%-43%14%7%-14%-5%-19%81%-13%-9%
230%-7%17%-2%7%-3%-11%-31%-16%-25%-12%42%-41%
22-4%17%-12%4%-15%-14%18%20%12%9%-7%0%27%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 51/100

Weak · Downtrend · Strong

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$147.20M

P/E ratio

52W high

$7.78

52W low

$1.17

Volume

3,34,396

Beta

1.11

Related stocks in Healthcare

Frequently asked questions

What is Treace Medical Concepts, Inc. share price today?
Treace Medical Concepts, Inc. (TMCI) last traded around $2.78 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does TMCI have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TMCI. Download the app for real-time alerts.
How can I analyze Treace Medical Concepts, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro